| Fry's Food And Drug | |
| 87 E Williams Field Rd, Gilbert, Arizona 85295 | |
| (480) 726-3813 |
| Name | Fry's Food And Drug |
|---|---|
| Organization Name | Smiths Food & Drug Centers Inc |
| Location | 87 E Williams Field Rd, Gilbert, Arizona 85295 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (480) 726-3813 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A phase 2 clinical trial in young adults with Down syndrome of a drug being investigated for the treatment of Alzheimer's disease supports further investigation of its potential.
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg (base), 50 mg (base) and 100 mg (base). This product is manufactured in Mylan's Morgantown, W.Va. facility.
Today's headlines include a series of reports detailing who makes up Romney's so-called "47 percent" who get tax breaks and what federal assistance they receive - whether it is Medicare, Medicaid or another entitlement program.
ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.
› Verified 3 days ago
| NPI Number | 1013952027 |
| Organization Name | SMITHS FOOD & DRUG CENTERS INC |
| Doing Business As | FRYS FOOD AND DRUG |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 87 E Williams Field Rd, Gilbert, AZ 85295 |
| Phone Number | 480-726-3813 |
News Archive
A phase 2 clinical trial in young adults with Down syndrome of a drug being investigated for the treatment of Alzheimer's disease supports further investigation of its potential.
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg (base), 50 mg (base) and 100 mg (base). This product is manufactured in Mylan's Morgantown, W.Va. facility.
Today's headlines include a series of reports detailing who makes up Romney's so-called "47 percent" who get tax breaks and what federal assistance they receive - whether it is Medicare, Medicaid or another entitlement program.
ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.
› Verified 3 days ago
News Archive
A phase 2 clinical trial in young adults with Down syndrome of a drug being investigated for the treatment of Alzheimer's disease supports further investigation of its potential.
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg (base), 50 mg (base) and 100 mg (base). This product is manufactured in Mylan's Morgantown, W.Va. facility.
Today's headlines include a series of reports detailing who makes up Romney's so-called "47 percent" who get tax breaks and what federal assistance they receive - whether it is Medicare, Medicaid or another entitlement program.
ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.
› Verified 3 days ago
Apria Healtcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2085 S Blue Jay Dr, Gilbert, Arizona 85295 Phone: (602) 313-6826 | |
Banner Home Care Arizona Type: Durable Medical Equipment & Medical Supplies Supplier Location: 275 E Germann Rd, Gilbert, Arizona 85297 Phone: (480) 657-1000 | |
Cvs Pharmacy #03272 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2371 E Guadalupe Rd, Gilbert, Arizona 85234 Phone: (480) 507-5399 | |
Cvs Pharmacy #03268 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 765 S Lindsay Rd, Gilbert, Arizona 85296 Phone: (480) 635-8518 | |
Cvs Pharmacy #08365 Type: Community/Retail Pharmacy Location: 2428 S Val Vista Dr, Gilbert, Arizona 85295 Phone: (480) 917-7467 |